Miscellaneous


 TitlePublished DateAuthor(s)
ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI PatientsSeptember 03, 2014Yael L. Maxwell
RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 YearsSeptember 03, 2014Caitlin E. Cox
TVT HeaderJune 16, 2014TCTMD
A Prospective, Multicenter, Randomized Trial of YINYI Polymer-Free Paclitaxel-Eluting Stent vs. Durable Polymer Sirolimus-Eluting Stent in the Treatment of Coronary Artery DiseaseMarch 22, 2014Yong Huo
A Prospective, Randomized Trial of Dual-Axis Rotational vs. Standard Coronary AngiographyMarch 22, 2014Zhi-geng Jin
An Angiographic Tool for Risk PrEdiction of Side Branch OccLusion in Coronary Bifurcation InterVEntion: RESOLVE score systemMarch 22, 2014Ke-fei Dou
Clinical outcomes of paclitaxel coated balloon angioplasty in an unselected patient population with drug eluting stent in-stent restenosis: Results from the French GARO RegistryMarch 22, 2014M Bedossa
CREDIT I: A First-In-Man Study of the Second Generation EXCEL Biodegradable Polymer Sirolimus-Eluting Stent - 4-Month Clinical, Angiographic, and OCT ResultsMarch 22, 2014Han Yaling
First Report of DAPT and CoCr Everolimus-Eluting Stent in Chinese Population: Two-Year Results from the Prospective Multicenter SEEDS Study - An Investigator Sponsored Study (ISS)March 22, 2014Yelin Zhao
Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stents at 3 months follow-up: The BuMA-OCT Randomized TrialMarch 22, 2014Yao-Jun Zhang
RESOLUTE China Registry: 1 Year (N = 1800) and 2 Year (N = 830) Outcomes from an All-Comers Chinese Population of Patients Implanted with the Resolute™ Zotarolimus-Eluting StentMarch 22, 2014Dr. Chen Shaoliang
XIENCE V China RCT 2 Year Results: A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting StentMarch 22, 2014Gao Runlin
A Prospective, Randomized Trial of Chinese Medicine Tongxinluo to Attenuate High On-Treatment Platelet Reactivity in Patients After Percutaneous Coronary InterventionMarch 21, 2014Yaling Han
AIR-CTO Trial Comparison of Angiography- versus IVUS- guided Stent Implantation for Chronic Total Coronary Occlusion RecanalizationMarch 21, 2014Shao-Liang Chen
Absorb Extend: Clinical Program up dateMarch 20, 2014Alexandre Abizaid
Addressing the New Enemies: In-BRS Restenosis, Thrombosis, Fractures and Beyond!March 20, 2014Patrick W. Serruys
BVS in Acute Myocardial InfarctionMarch 20, 2014Dr Tan Huay Cheem
Case Study of China-Based Innovation: Pulmonary Arterial Denervation(PADN)March 20, 2014Shaoliang Chen
Clinical Outcomes with BRS in Long Lesions and Overlapping ScaffoldsMarch 20, 2014P.C. Smits
Clinical outcomes with BVS in Unselected “Real World” PracticeMarch 20, 2014Corrado Tamburino
DES Innovation from China - Target Eluting StentMarch 20, 2014Qiyi Luo
From Coronary Revascularization to Vascular Restoration: Why Do We Need BRS?March 20, 2014Gregg W. Stone
Funding Strategies and OpportunitiesMarch 20, 2014Eric Zi
INNOVATIONS AND INTERVENTIONAL CARDIOLOGY: A Personal JourneyMarch 20, 2014Dr. Yuval Binur
Interventional Innovation in China: Current and Future Landscape Value of Team Building for the Successful Development of Emerging TechnologiesMarch 20, 2014Juan F. Granada
Polymeric BRS Are the Way to Go!March 20, 2014Patrick W. Serruys
Science Behind Bioresorbable Vascular ScaffoldsMarch 20, 2014Renu Virmani
Session V: Bioabsorbable scaffold - Will this be the default therapy of the next decade? Bifurcation lesionsMarch 20, 2014Antonio Colombo
Single Center Experience with the first 381 Absorb ImplantationsMarch 20, 2014Christoph K. Naber
Why do I prefer Metallic BRSMarch 20, 2014Ron Waksman
12345678910...